|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
37.850 +0.450 (+1.203%) | 2020/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | 2016/12 RMB(K¥) | ||
| Turnover | 13,965,179 | -0.852% | 28,389,277 | 24,713,875 | 18,361,608 | 14,505,584 | |
| Cost of Sales | (6,215,872) | 11.018% | (11,543,421) | (10,365,309) | (7,608,953) | (6,718,364) | |
| Gross Profit | 7,749,307 | -8.683% | 16,845,856 | 14,348,566 | 10,752,655 | 7,787,220 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (42,765) | 95.114% | (97,114) | (27,162) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 652,406 | -11.131% | 1,431,414 | 1,348,997 | 1,351,323 | 1,342,808 | |
| Profit / (Loss) before Taxation | 2,301,688 | 4.806% | 4,525,753 | 3,579,593 | 4,061,717 | 3,571,549 | |
| Taxation | (392,081) | 4.133% | (782,231) | (559,711) | (476,458) | (350,207) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (194,897) | -35.785% | (421,904) | (311,959) | (460,759) | (415,505) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,714,710 | 13.099% | 3,321,618 | 2,707,923 | 3,124,500 | 2,805,837 | |
| Net Finance Costs / (Income) | 331,442 | -27.993% | 888,042 | 783,920 | 498,317 | 407,272 | |
| Depreciation & Amortisation | 836,268 | 12.971% | 1,520,479 | 1,346,916 | 945,910 | 739,234 | |
| Directors' Emoluments | -- | -- | 20,271 | 25,351 | 21,770 | 20,280 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 67.000 | -- | 130.000 | 107.000 | 127.000 | 121.000 |
| DPS (cts) | 0.000 | -- | 39.000 | 32.000 | 38.000 | 35.000 |
| Dividend Payout Ratio (%) | -- | -- | 30.000% | 29.907% | 29.921% | 28.926% |
| Cash flow per share ($) | -- | -- | 1.257 | 1.169 | 1.049 | 0.907 |
| NBV per share ($) | 12.869 | -- | 12.420 | 10.894 | 10.128 | 9.167 |
| Remarks: | Real time quote last updated: 22/01/2021 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,714,710 |
| %Change | 13.099% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 12.869 |